Browne Jacobson advise on the disposal of international chemical manufacturer

Browne Jacobson’s corporate lawyers have successfully advised the shareholders of specialist chemical manufacturer, Amity International on its acquisition by Belimed AG, a subsidiary of Metall Zug AG.

27 July 2022

Browne Jacobson’s corporate lawyers have successfully advised the shareholders of specialist chemical manufacturer, Amity International on its acquisition by Belimed AG, a subsidiary of Metall Zug AG.

Founded in 2005, Amity International which is headquartered in Barnsley, South Yorkshire, produces a broad range of specialist chemicals, disinfectants, enzymatics and detergents for cleaning and decontamination for the aerospace, healthcare, food and industrial sectors. The business manufactures overs 2,000 different types of chemicals using innovative technologies. In 2019 the business launched the world’s first virtual reality infection prevention training platform.

Belimed which is headquartered in Zug, Switzerland is a leading supplier of medical and surgical instrument sterilization, disinfection and cleaning products and services. The acquisition will support Belimed’s rapidly growing product portfolio and support both businesses in their common ambition to reduce hospital acquired infections.

The Browne Jacobson corporate team advising the shareholders of Amity International was led by Manchester based corporate finance partner, Ryan Brown, with support from Manchester based associate, Harpinder Nahl. Manchester based senior associate, Michael Parkinson supported on the property elements of the deal, Nottingham based associate Joe Babos gave employment advice and Birmingham based senior associate, Rebecca Burge supported on the tax side of the transaction.

Ram Singh, Managing Director at Amity International said: “We are pleased to have found Belimed as the perfect and competent partner for Amity International. Belimed combines equipment, chemistry and service into one high-performance workflow solution. The transaction will enable Amity to reach a higher level of success.

“Amity will continue its growth trajectory with its own brand while becoming a key supplier and innovator for the rapidly growing Belimed Protect portfolio.

“We have been impressed with the support and strong commercial advice we received from the team at Browne Jacobson. There were a number of complexities with this transaction which required real collaboration between all parties, and I was always impressed by the responsiveness, pragmatism and support Ryan and team provided. They were always able to breakdown and contextualise technical legal issues into points we could understand and therefore respond to, and we are very grateful for that.”

Partner Ryan Brown added: "We are pleased to have advised Amity International and its shareholders on this key partnering with Belimed. Over the last 30 years Ram and Mokhles have built a robust business and a trusted brand that has a reputation for providing high quality chemical products and services that are essential to the sectors they support, particularly the healthcare sector. With the clear synergies between the businesses, I am sure that Amity will integrate seamlessly into the Belimed family."

Browne Jacobson’s national corporate finance practice is ranked by Experian as one of the country’s leading corporate finance teams. It operates from our offices in Birmingham, London, Manchester, and Nottingham and is made up of over 50 expert corporate, private equity, venture capital (VC) and banking & finance lawyers delivering multi-layered transactions across a diverse range of sectors.

The team works collaboratively with a rich, diverse and longstanding portfolio of domestic and international clients including, fast growing start-ups, FTSE 100 companies, private equity investors and the UKs leading banking institutions.

Contact

Contact

Lakhbir Rakar

PR Manager

lakhbir.rakar@brownejacobson.com

+44 (0)121 237 3926

View profile
Can we help you? Contact Lakhbir

Related expertise

You may be interested in...